Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

16
Number of overlapping holdings
32.0%
% of PINK's 54 holdings also in HRTS
40.0%
% of HRTS's 40 holdings also in PINK
Overlap by Weight
Sector Drift (PINK minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PINK |
Weight in HRTS |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 9.9% | 9.8% | 9.8% | |
UNITEDHEALTH GROUP INC | 5.2% | 5.9% | 5.2% | |
THERMO FISHER SCIENTIFIC INC | 3.4% | 2.9% | 2.9% | |
GILEAD SCIENCES INC | 4.4% | 2.6% | 2.6% | |
ABBVIE INC | 4.7% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
PINK Overweight Relative to HRTS
ARCUTIS BIOTHERAPEUTICS INC | 6.6% | |
INTUITIVE SURGICAL INC | 5.1% | |
RESMED INC | 4.9% | |
JOHNSON & JOHNSON | 4.7% | |
REGENERON PHARMACEUTICALS | 4.5% | |
PACIRA PHARMACEUTICALS INC | 3.4% | |
PURECYCLE TECHNOLOGIES INC | 3.3% | |
3M CO | 2.7% | |
CARDINAL HEALTH INC | 2.6% | |
CIGNA CORPORATION | 2.5% |
PINK Underweight Relative to HRTS
BRIDGEBIO PHARMA, INC. | -4.3% | |
ASTRAZENECA PLC | -4.1% | |
ROCHE HOLDINGS LTD-SPONS ADR | -3.7% | |
NOVO NORDISK A/S-B | -3.7% | |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% | |
VERTEX PHARMACEUTICALS INC | -3.2% | |
MERCK & CO. INC. | -3.1% | |
BOSTON SCIENTIFIC CORP | -3.1% | |
MEDTRONIC PLC | -2.7% | |
NOVARTIS AG | -2.7% |